The SIS combines albumin and LMR values and has been noted to be superior to other blood-borne markers like the NLR, modified Glasgow Prognostic Score, and lymphocyte C-reactive protein score for patients with cancer (18, 28). This evidence concerns the gene ALB and cancer.